Company intelligence / Profile preview

Marita Group

Ownership: Private
Development stage: Other

Overview

Marita Group, through its Smart Marita division, contributed to the COVID‑19 response by manufacturing masks and hand sanitizers. It also developed air purification/disinfection systems using essential oils for public spaces. There are no reported clinical trials or results related to pharmaceuticals or advanced medical therapies[6].

Therapeutic areas: Infectious Diseases
Modalities: Device (e.g., air purification systems)Personal protective equipment (PPE) such as masks and hand sanitizers
Industry: Consumable Medical Devices

Partnerships

No major pharmaceutical/biotech partnerships identified. One past collaboration with Triton Pharmaceuticals for cancer detection technology was mentioned in news from 2018 but appears limited in scope and not ongoing as a core business line[3].

Beyond the preview

Go deeper on Marita Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marita Group.

Explore the full profile